Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v2.4.1.9
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Statement of Cash Flows [Abstract]    
NET CASH USED IN OPERATING ACTIVITIES $ (1,392)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations $ (636)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
INVESTING ACTIVITIES    
Purchase of medical equipment and property (3,670)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (1,127)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Proceeds from sale of medical equipment and property 1,118us-gaap_ProceedsFromSaleOfProductiveAssets 1,252us-gaap_ProceedsFromSaleOfProductiveAssets
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES (2,552)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations 125us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
FINANCING ACTIVITIES    
Principal payments on revolving credit facility, term loans and capital lease obligations (38,633)us-gaap_RepaymentsOfLongTermCapitalLeaseObligations (14,394)us-gaap_RepaymentsOfLongTermCapitalLeaseObligations
Cash proceeds from revolving credit facility 45,980us-gaap_ProceedsFromRepaymentsOfDebt 14,263us-gaap_ProceedsFromRepaymentsOfDebt
Debt issuance costs (147)us-gaap_PaymentsOfDebtIssuanceCosts  
Principal payments on capital lease obligation (547)infu_PrincipalPaymentsOnCapitalLeaseObligations  
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 6,653us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations (131)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Net change in cash and cash equivalents 2,709us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (642)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents, beginning of period 515us-gaap_CashAndCashEquivalentsAtCarryingValue 1,138us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents, end of period $ 3,224us-gaap_CashAndCashEquivalentsAtCarryingValue $ 496us-gaap_CashAndCashEquivalentsAtCarryingValue